Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract. (Q37497846)
Jump to navigation
Jump to search
scientific article published on 12 December 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract. |
scientific article published on 12 December 2016 |
Statements
Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract (English)
V Branchi
P Schaefer
A Kania
P Lingohr
J C Kalff
N Schäfer
G Kristiansen
D Dietrich
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference